‘Total treatment failure’: Terrifying ‘superbug’ crisis will kill millions and devastate world economy
We’re lurching towards an “alarming” crisis that will claim millions of lives and cost billions of dollars – and “nobody is immune”.
From news.com.au story today. Specific reference to UTI's amongst the concerns in developing AMR infection crisis. Would be great if we could show evidence of efficacy against multi drug resistant UTI infections as it seems we did in sinusitis and burns infections previously. Surely at some point we will start to generate interest.
https://www.news.com.au/lifestyle/health/total-treatment-failure-terrifying-superbug-crisis-will-kill-millions-and-devastate-world-economy/news-story/80546cad01d6801e00fe45833f3fb96b
During a webinar ahead of the release of the report, Curbing antimicrobial resistance: A technology-powered, human-driven approach to combating the ‘silent pandemic’, the CSIRO’s lead of the Minimising Antimicrobial Resistance Mission, Dr Branwen Morgan, said there was a “social imperative to act now” as a matter of “urgency” before we reach a point of “total treatment failure”.And she said without immediate action, nobody would be able to escape what was to come, whether it be children with simple ear infections or women struck down by common urinary tract infections.“We are seeing increased failure of the antibiotics we have. Half of all women will get a UTI, and we already know the first-line drugs they are being given first off aren’t working,” she said.
- Forums
- ASX - By Stock
- [VIDEO] Recce Pharma (ASX:RCE) selects CMAX for phase I/II UTI clinical trial
RCE
recce pharmaceuticals ltd
Add to My Watchlist
21.9%
!
44.5¢

‘Total treatment failure’: Terrifying ‘superbug’ crisis will...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
44.5¢ |
Change
0.080(21.9%) |
Mkt cap ! $128.6M |
Open | High | Low | Value | Volume |
37.5¢ | 44.5¢ | 37.5¢ | $191.2K | 477.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12222 | 44.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 10976 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12222 | 0.440 |
2 | 8000 | 0.425 |
1 | 50000 | 0.420 |
1 | 4175 | 0.415 |
2 | 69894 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 10976 | 2 |
0.460 | 14304 | 2 |
0.470 | 100000 | 1 |
0.490 | 8000 | 1 |
0.500 | 13381 | 3 |
Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online